,Response,Percentage of value
0,Global pharma,45%
1,Specialty pharma,23%
2,Generics,11%
3,China pharma,10%
4,Japan pharma,6%
5,Development stage biotechnology*,3%
6,Animal health,1%
7,Korean pharma,1%
